Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1940 1
1962 1
1983 2
1984 1
1985 3
1986 1
1988 1
1989 2
1990 1
1991 5
1992 3
1993 2
1994 1
1995 1
1996 4
1997 12
1998 8
1999 3
2000 5
2001 10
2002 13
2003 9
2004 23
2005 21
2006 37
2007 41
2008 27
2009 53
2010 47
2011 94
2012 108
2013 133
2014 145
2015 148
2016 212
2017 215
2018 245
2019 283
2020 358
2021 434
2022 501
2023 581
2024 640
2025 686
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,622 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. Among authors: luo t. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Extramedullary Multiple Myeloma: Challenges and Opportunities.
Ho M, Paruzzo L, Minehart J, Nabar N, Noll JH, Luo T, Garfall A, Zanwar S. Ho M, et al. Among authors: luo t. Curr Oncol. 2025 Mar 20;32(3):182. doi: 10.3390/curroncol32030182. Curr Oncol. 2025. PMID: 40136386 Free PMC article. Review.
Molecular pathways and diagnosis in spatially resolved Alzheimer's hippocampal atlas.
Wang P, Han L, Wang L, Tao Q, Guo Z, Luo T, He Y, Xu Z, Yu J, Liu Y, Wu Z, Xu B, Jin B, Wei Y, Yang Y, Cheng M, Jiang Y, Tian C, Zheng H, Fan Z, Jiang P, Gao Y, Wu J, Wang S, Sun B, Fang Z, Lei J, Luo B, Wen H, Peng G, Tang Y, Yang T, Chen J, Zhuang Z, Su X, Pan C, Zhu K, Shen Y, Liu S, Bao A, Yao J, Wang J, Xu X, Li XM, Liu L, Duan S, Zhang J. Wang P, et al. Among authors: luo t. Neuron. 2025 Jul 9;113(13):2123-2140.e9. doi: 10.1016/j.neuron.2025.03.002. Epub 2025 Mar 31. Neuron. 2025. PMID: 40168986
Voxel-level radiomics and deep learning for predicting pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy.
Zhang Z, Luo T, Yan M, Shen H, Tao K, Zeng J, Yuan J, Fang M, Zheng J, Bermejo I, Dekker A, Ruysscher D, Wee L, Zhang W, Jiang Y, Ji Y. Zhang Z, et al. Among authors: luo t. J Immunother Cancer. 2025 Mar 15;13(3):e011149. doi: 10.1136/jitc-2024-011149. J Immunother Cancer. 2025. PMID: 40090670 Free PMC article.
4,622 results